We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
SPX Corp
SPXC
$11B
| $2.03M | 0.03% |
170,441
-289,659
| -63% | -$4.45M |
|
|
GRSHU
427
DELISTED
Gores Holdings, Inc.
GRSHU
| $2.03M | 0.03% |
+200,000
| New | +$2.02M |
|
|
HME
428
DELISTED
HOME PROPERTIES, INC
HME
| $2.01M | 0.03% |
+26,940
| New | +$1.99M |
|
|
CHMT
429
DELISTED
Chemtura Corporation
CHMT
| $2M | 0.03% |
70,043
+30,043
| +75% | +$822K |
|
|
SPR
430
CALL
DELISTED
Spirit AeroSystems
SPR
| $1.93M | 0.03% |
+40,000
| New | +$2.13M |
|
431
News Corp Class A
NWSA
$14.9B
| $1.93M | 0.03% |
+153,116
| New | +$2.13M |
|
|
AWH
432
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $1.91M | 0.03% |
+50,100
| New | +$2.08M |
|
433
B2Gold
BTG
$5B
| $1.9M | 0.03% |
1,800,000
+1,782,900
| +10,426% | +$2.17M |
|
|
TRAK
434
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $1.87M | 0.03% |
+29,676
| New | +$1.85M |
|
435
Louisiana-Pacific
LPX
$5.06B
| $1.84M | 0.03% |
+129,570
| New | +$2.06M |
|
|
FNHC
436
DELISTED
FedNat Holding Company Common Stock
FNHC
| $1.83M | 0.03% |
+76,400
| New | +$1.79M |
|
|
FLXN
437
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.83M | 0.03% |
123,492
-147,508
| -54% | -$3.46M |
|
438
Essent Group
ESNT
$6.08B
| $1.78M | 0.02% |
+71,800
| New | +$1.97M |
|
439
Albemarle
ALB
$13.9B
| $1.78M | 0.02% |
+40,354
| New | +$1.97M |
|
|
CVA
440
DELISTED
Covanta Holding Corporation
CVA
| $1.77M | 0.02% |
+101,530
| New | +$2.01M |
|
|
AKRX
441
DELISTED
Akorn Inc
AKRX
| $1.77M | 0.02% |
62,100
+7,977
| +15% | +$330K |
|
442
PUT
Advanced Micro Devices
AMD
$776B
| $1.72M | 0.02% |
+1,000,000
| New | +$1.88M |
|
443
RadNet
RDNT
$5.02B
| $1.68M | 0.02% |
302,600
+28,100
| +10% | +$181K |
|
444
Globus Medical
GMED
$10.7B
| $1.67M | 0.02% |
80,700
-262,337
| -76% | -$6.64M |
|
|
PBCT
445
DELISTED
People's United Financial Inc
PBCT
| $1.65M | 0.02% |
105,000
-27,171
| -21% | -$431K |
|
|
ZSAN
446
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.64M | 0.02% |
593
-14
| -2% | -$78.6K |
|
447
Forum Energy Technologies
FET
$708M
| $1.63M | 0.02% |
+6,663
| New | +$2.04M |
|
448
Stellantis
STLA
$21.7B
| $1.62M | 0.02% |
+192,097
| New | +$1.84M |
|
|
SLH
449
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $1.62M | 0.02% |
+29,927
| New | +$1.36M |
|
450
Yelp
YELP
$1.45B
| $1.61M | 0.02% |
74,479
-39,504
| -35% | -$1.1M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.